Journal of Antimicrobial Chemotherapy (2002) 49, 7-10
© 2002 The British Society for Antimicrobial Chemotherapy
Leading articles |
Antibiotic resistance surveillance: action for international studies
Department of Clinical Microbiology, Western General Hospital, Edinburgh EH4 2XU, UK
Introduction
Ten years ago O'Brien et al.1 described the position on antibiotic resistance surveillance as follows: ‘There are no reliable data in this area—simply fragments of information and anecdotes that we use to draw an overall picture’. Recent reviews on this topic point to much activity but suggest that in many areas little has changed.2–7 At the start of the 21st century one of the most pressing medical problems is the rise of antimicrobial resistance, and surveillance is generally seen as being a principal weapon in the global response to this threat. However, if surveillance is to make such a contribution it needs to resolve its organizational and scientific difficulties. Recent definitions of surveillance in public health8 and antimicrobial resistance9 settings have failed to address these and have ignored the essential aspect of drug usage. Although much contemporary work has focused on international programmes, antimicrobial resistance surveillance remains peppered with
Surveillance programme problems
Duplicates
Presentation of susceptibility data
National and international surveillance programmes
Notes
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Pereira Silveira, J. M. Torres-Rodriguez, E. Alvarado-Ramirez, F. Murciano-Gonzalo, M. Dolande, M. Panizo, and V. Reviakina MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii J. Med. Microbiol., December 1, 2009; 58(12): 1607 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gautam, J. Shankar, T. Madan, R. Sirdeshmukh, C. S. Sundaram, W. N. Gade, S. F. Basir, and P. U. Sarma Proteomic and Transcriptomic Analysis of Aspergillus fumigatus on Exposure to Amphotericin B Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4220 - 4227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Trofa, A. Gacser, and J. D. Nosanchuk Candida parapsilosis, an Emerging Fungal Pathogen Clin. Microbiol. Rev., October 1, 2008; 21(4): 606 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Cowen and W. J. Steinbach Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance Eukaryot. Cell, May 1, 2008; 7(5): 747 - 764. [Full Text] [PDF]
|
|
|
|
|
|
E. Alvarado-Ramirez and J. M. Torres-Rodriguez In Vitro Susceptibility of Sporothrix schenckii to Six Antifungal Agents Determined Using Three Different Methods Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2420 - 2423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Shen, M.-Y. Wang, C.-Y. Wang, T.-C. Tsai, H.-Y. Tsai, Y.-F. Lee, and L.-C. Wei Clearance of Intravitreal Voriconazole Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2238 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vandeputte, G. Tronchin, T. Berges, C. Hennequin, D. Chabasse, and J.-P. Bouchara Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth Antimicrob. Agents Chemother., March 1, 2007; 51(3): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lau, S. Chen, T. Sorrell, D. Carter, R. Malik, P. Martin, and C. Halliday Development and Clinical Application of a Panfungal PCR Assay To Detect and Identify Fungal DNA in Tissue Specimens J. Clin. Microbiol., February 1, 2007; 45(2): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Vogelsinger, S. Weiler, A. Djanani, J. Kountchev, R. Bellmann-Weiler, C. J. Wiedermann, and R. Bellmann Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion J. Antimicrob. Chemother., June 1, 2006; 57(6): 1153 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Croft, S. Sundar, and A. H. Fairlamb Drug Resistance in Leishmaniasis Clin. Microbiol. Rev., January 1, 2006; 19(1): 111 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pfaller, S. A. Messer, L. Boyken, H. Huynh, R. J. Hollis, and D. J. Diekema In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3518 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pfaller and D. J. Diekema Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility J. Clin. Microbiol., October 1, 2002; 40(10): 3551 - 3557. [Full Text] [PDF]
|
|